lysine has been researched along with Sarcoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Alaggio, R; Alexandrescu, S; Lidov, HG; Ligon, KL; Meredith, DM; Novello, M; Vargas, SO | 1 |
| Erickson, SW; Gorlick, R; Han, R; Houghton, PJ; Kurmasheva, RT; Roth, M; Smith, MA; Teicher, BA | 1 |
| Allis, CD; Andrulis, IL; Bechet, D; Chi, P; De Jay, N; Dickson, BC; Fahiminiyah, S; Garcia, BA; Grynspan, D; Hameed, M; Hoelper, D; Jabado, N; Jain, SU; Jani, KS; Lewis, PW; Lu, C; Lundgren, SM; Majewski, J; Molden, RC; Muir, TW; Murphy, D; Nadaf, J; Papillon-Cavanagh, S; Pawel, BR; Ran, L; Sawyer, SL; Thompson, CB; Turcotte, RE; Venneti, S; Wunder, JS | 1 |
| Jung, S; Kasper, B | 1 |
| Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW; Roomi, NW | 1 |
| Movva, S; Verschraegen, C | 1 |
| PEREVOSHCHIKOVA, KA | 1 |
2 review(s) available for lysine and Sarcoma
| Article | Year |
|---|---|
Palifosfamide, a bifunctional alkylator for the treatment of sarcomas.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Ifosfamide; Lysine; Sarcoma; Soft Tissue Neoplasms | 2010 |
Systemic management strategies for metastatic soft tissue sarcoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dioxoles; Doxorubicin; Gemcitabine; Humans; Ifosfamide; Lysine; Paclitaxel; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin | 2011 |
5 other study(ies) available for lysine and Sarcoma
| Article | Year |
|---|---|
Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
Topics: Adolescent; Aged; Biomarkers, Tumor; Brain Neoplasms; Child; DEAD-box RNA Helicases; Female; High-Throughput Nucleotide Sequencing; Histones; Humans; Immunohistochemistry; Infant; Lysine; Male; Methylation; Mutation; Ribonuclease III; Sarcoma; Transducin | 2021 |
In vivo evaluation of the lysine-specific demethylase (KDM1A/LSD1) inhibitor SP-2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consortium (PPTC).
Topics: Animals; Bone Neoplasms; Cell Line, Tumor; Child; Enzyme Inhibitors; Histone Demethylases; Humans; Lysine; Rhabdomyosarcoma; Sarcoma; Xenograft Model Antitumor Assays | 2021 |
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape.
Topics: Animals; Bone Neoplasms; Carcinogenesis; Child, Preschool; Chondroblastoma; Gene Expression Regulation, Neoplastic; Histones; Humans; Lysine; Mesenchymal Stem Cells; Methionine; Methylation; Methyltransferases; Mice; Mutation; Mutation, Missense; Neoplastic Stem Cells; Nucleosomes; Polycomb Repressive Complex 1; Sarcoma | 2016 |
Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Topics: Antineoplastic Agents; Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Food; Humans; Lysine; Plant Extracts; Proline; Sarcoma; Tea; Uterine Neoplasms | 2012 |
THE ACTION OF SOME METABOLIC INHIBITORS UPON THE ACCUMULATION OF AMINO ACIDS AND THE INCORPORATION OF THE LATTER INTO THE PROTEINS OF THE TUMOR CELLS IN VITRO.
Topics: Amino Acids; Animals; Antineoplastic Agents; Carcinoma, Brown-Pearce; Carcinoma, Ehrlich Tumor; Glycine; Histocytochemistry; In Vitro Techniques; Lysine; Melphalan; Methionine; Mice; Neoplasm Proteins; Pharmacology; Proteins; Rabbits; Research; Sarcoma; Sarcoma, Experimental; Thiotepa; Tyrosine | 1964 |